Daniel L. Menichella
Chief Executive Officer
Health care
CureVac
Germany
Biography
Daniel L. Menichella joined CureVac in the beginning of 2017. He has over 15 years of executive and leadership experience within the pharmaceutical and biotech fields, including CBO, SVP, and VP roles. Before joining CureVac, he was Chief Business Officer of Bamboo Therapeutics. Other stations in his career were Applied Genetic Technologies Corp., Zyngenia Inc., Talecris Biotherapeutics Holdings Corp. and Merck KGaA. Dan holds an MBA of the University of North Carolina and an BA from Harvard University.
Research Interest
Pharmacology and biotechnology
